Compare PRPO & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRPO | UG |
|---|---|---|
| Founded | N/A | 1942 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Package Goods/Cosmetics |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.4M | 27.7M |
| IPO Year | N/A | N/A |
| Metric | PRPO | UG |
|---|---|---|
| Price | $23.38 | $6.19 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 7.7K | ★ 13.1K |
| Earning Date | 11-14-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 11.36% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | ★ $22,800,000.00 | $10,060,322.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $14.44 |
| Revenue Growth | ★ 30.95 | N/A |
| 52 Week Low | $3.90 | $5.58 |
| 52 Week High | $28.50 | $11.98 |
| Indicator | PRPO | UG |
|---|---|---|
| Relative Strength Index (RSI) | 50.08 | 53.31 |
| Support Level | $22.40 | $6.08 |
| Resistance Level | $24.60 | $6.25 |
| Average True Range (ATR) | 1.32 | 0.09 |
| MACD | -0.20 | 0.04 |
| Stochastic Oscillator | 43.69 | 80.00 |
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.